Tian, T., Zhu, Y., Shang, K., Shi, H., Xu, R., Li, M., . . . Zhang, F. (2025, May). FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against <i>Brucella</i>. Vaccines.
Chicago Style (17th ed.) CitationTian, Tingting, et al. "FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella." Vaccines May. 2025.
MLA引文Tian, Tingting, et al. "FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella." Vaccines, May. 2025.
警告:這些引文格式不一定是100%准確.
